A Clinical Trial to Evaluate a Melanoma Helper Peptide Vaccine Plus Dabrafenib and Trametinib

计划入组 8 人 · 首次发布于 2015 年 3 月 6 日

Clinical and Functional Retinal Changes Associated With BRAF/MEK Inhibitor Therapy in Patients With Malignant Melanoma

计划入组 14 人 · 首次发布于 2026 年 2 月 23 日

Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor Therapy

计划入组 40 人 · 首次发布于 2024 年 6 月 24 日

SERD/MEK inhibitor(Baylor College of Medicine)

MEK Inhibitors (Bayer HealthCare)

Covalent MEK inhibitors(Immuneering)

Corvus Pharmaceuticals

United States

Kura Oncology

United States

Odyssey Therapeutics

Pasithea Therapeutics Secures $60 Million Funding to Advance MEK Inhibitor for Neurofibromatosis Treatment

Pasithea's PAS-004 Outperforms FDA-Approved MEK Inhibitor in Preclinical IBD Study

FDA Approves SpringWorks' Gomekli (Mirdametinib) for Neurofibromatosis Type 1